A Pakistani special court mandated an open trial for jailed former PM Imran Khan inside the Adiala jail premises in the garrison city of Rawalpindi, with the government submitting reports citing threats to his life. The special court, established...

Starting on December 1, Malaysia has eliminated the need for Indian tourists and business travellers to have a visa

Modi ModiModi, an emotional cry from the masses heard right across Bharat, but as we PIO and NRI community know, it’s the same chorus of support right across the globe as well. Against this backdrop, and after successive humiliating Rahul, Sonia...

Expectations of policy continuity by the BJP-led government at the Centre after the strong mandate at state polls changed investor sentiment on Dalal Street on Monday. Aggressive buying led by domestic investors pushed the sensex up by nearly...

Jailed former prime minister Imran Khan's party elected Barrister Gohar Ali Khan as the new chairman, days before the top election body's deadline for the party to hold organisational polls to retain 'bat' as its election symbol

The Securities Appellate Tribunal (SAT) set aside the penalty imposed by Securities and Exchange Board of India (Sebi) on Reliance Industries’s (RIL) chairman Mukesh Ambani and two other entities in a case related to alleged manipulative trading...

The fashion business SMCP, which owns the French fashion labels Maje and Sandro, said that it has reached an agreement with Reliance to grow into India

The Reserve Bank of India signed an agreement with the Bank of England (BoE) on exchange of information for settlement of bond trades through Clearing Corporation of India Ltd (CCIL).

Thanks to a significant increase in the group's stock price that contributed over £11 billion to its market capitalisation, Gautam Adani is once again included among the world's 20 richest persons. According to the Bloomberg Billionaire ranking,...

Ahmedabad based Zydus Lifesciences in regulatory filing said it has received final approval from the US Food and Drug Administration (USFDA) for its generic version of Ivabradine tablets indicated for the treatment of heart failure.